Report Detail

Chemical & Material Global Oligonucleotides Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3543035
  • |
  • 20 June, 2019
  • |
  • Global
  • |
  • 139 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Chemical & Material

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Scope of the Report:
Oligonucleotide is widely used in Research, Pharmaceutical and Diagnostic. The most proportion of Oligonucleotide used in Research, and the revenue in 2018 is 409.97 M USD. Moreover, increase in focus on targeted gene therapies has revolutionized treatment of incurable conditions caused by genetic mutations. Increase in demand for sequencing applications by clinical, diagnostic, academic, and drug development is witnessed by manufactures.
North America is the largest customer of Oligonucleotide, with a revenue market share nearly 37.51% in 2018. Europe is the second largest consumer of Oligonucleotide, enjoying revenue market share nearly 30.5% in 2018. Asian countries are recognized as the fastest adopters of sequencing, array technology, and PCR products due to rapid progress in genomics studies and the healthcare sector. Japan and China are considered as the most attractive markets with respect to expansion and growth opportunities present in these countries. In addition, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus aiding its growth.
The worldwide market for Oligonucleotides is expected to grow at a CAGR of roughly 9.6% over the next five years, will reach 1510 million US$ in 2024, from 952.8 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oligonucleotides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
DNA Oligos
RNA Oligos

Market Segment by Applications, can be divided into
Pharmaceutical
Research
Diagnostic

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oligonucleotides, with price, sales, revenue and global market share of Oligonucleotides in 2017 and 2018.
Chapter 3, the Oligonucleotides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligonucleotides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oligonucleotides market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oligonucleotides sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Oligonucleotides Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 DNA Oligos
      • 1.2.2 RNA Oligos
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pharmaceutical
      • 1.3.2 Research
      • 1.3.3 Diagnostic
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Integrated DNA Technologies
      • 2.1.1 Business Overview
      • 2.1.2 Oligonucleotides Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Integrated DNA Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Agilent
      • 2.2.1 Business Overview
      • 2.2.2 Oligonucleotides Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Agilent Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Sigma-aldrich
      • 2.3.1 Business Overview
      • 2.3.2 Oligonucleotides Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Sigma-aldrich Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Eurofins Genomics
      • 2.4.1 Business Overview
      • 2.4.2 Oligonucleotides Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Eurofins Genomics Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 L.G.C Biosearch Technologies
      • 2.5.1 Business Overview
      • 2.5.2 Oligonucleotides Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 L.G.C Biosearch Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Eurogentec S.A
      • 2.6.1 Business Overview
      • 2.6.2 Oligonucleotides Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Eurogentec S.A Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Nitto Denko Avecia Inc
      • 2.7.1 Business Overview
      • 2.7.2 Oligonucleotides Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Nitto Denko Avecia Inc Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 GenScript
      • 2.8.1 Business Overview
      • 2.8.2 Oligonucleotides Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 GenScript Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 BBI Life Sciences
      • 2.9.1 Business Overview
      • 2.9.2 Oligonucleotides Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 BBI Life Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 GeneDesign
      • 2.10.1 Business Overview
      • 2.10.2 Oligonucleotides Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 GeneDesign Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 TriLink BioTechnologies
      • 2.11.1 Business Overview
      • 2.11.2 Oligonucleotides Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 TriLink BioTechnologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 SGS DNA
      • 2.12.1 Business Overview
      • 2.12.2 Oligonucleotides Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 SGS DNA Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 LC Sciences
      • 2.13.1 Business Overview
      • 2.13.2 Oligonucleotides Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 LC Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Twist Bioscience
      • 2.14.1 Business Overview
      • 2.14.2 Oligonucleotides Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Twist Bioscience Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Creative Biogene
      • 2.15.1 Business Overview
      • 2.15.2 Oligonucleotides Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Creative Biogene Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 General Biosystems
      • 2.16.1 Business Overview
      • 2.16.2 Oligonucleotides Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 General Biosystems Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oligonucleotides Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oligonucleotides Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oligonucleotides Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oligonucleotides Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oligonucleotides Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oligonucleotides Market Analysis by Regions

    • 4.1 Global Oligonucleotides Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oligonucleotides Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oligonucleotides Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oligonucleotides Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oligonucleotides Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oligonucleotides Sales and Growth Rate (2014-2019)
    • 4.5 South America Oligonucleotides Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oligonucleotides Sales and Growth Rate (2014-2019)

    5 North America Oligonucleotides by Country

    • 5.1 North America Oligonucleotides Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oligonucleotides Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oligonucleotides Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oligonucleotides Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oligonucleotides Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oligonucleotides Sales and Growth Rate (2014-2019)

    6 Europe Oligonucleotides by Country

    • 6.1 Europe Oligonucleotides Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oligonucleotides Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oligonucleotides Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oligonucleotides Sales and Growth Rate (2014-2019)
    • 6.3 UK Oligonucleotides Sales and Growth Rate (2014-2019)
    • 6.4 France Oligonucleotides Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oligonucleotides Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oligonucleotides Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oligonucleotides by Country

    • 7.1 Asia-Pacific Oligonucleotides Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oligonucleotides Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oligonucleotides Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oligonucleotides Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oligonucleotides Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oligonucleotides Sales and Growth Rate (2014-2019)
    • 7.5 India Oligonucleotides Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oligonucleotides Sales and Growth Rate (2014-2019)

    8 South America Oligonucleotides by Country

    • 8.1 South America Oligonucleotides Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oligonucleotides Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oligonucleotides Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oligonucleotides Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oligonucleotides Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oligonucleotides Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oligonucleotides by Countries

    • 9.1 Middle East and Africa Oligonucleotides Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oligonucleotides Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oligonucleotides Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oligonucleotides Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oligonucleotides Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oligonucleotides Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oligonucleotides Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oligonucleotides Sales and Growth Rate (2014-2019)

    10 Global Oligonucleotides Market Segment by Type

    • 10.1 Global Oligonucleotides Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oligonucleotides Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oligonucleotides Revenue and Market Share by Type (2014-2019)
    • 10.2 DNA Oligos Sales Growth and Price
      • 10.2.1 Global DNA Oligos Sales Growth (2014-2019)
      • 10.2.2 Global DNA Oligos Price (2014-2019)
    • 10.3 RNA Oligos Sales Growth and Price
      • 10.3.1 Global RNA Oligos Sales Growth (2014-2019)
      • 10.3.2 Global RNA Oligos Price (2014-2019)

    11 Global Oligonucleotides Market Segment by Application

    • 11.1 Global Oligonucleotides Sales Market Share by Application (2014-2019)
    • 11.2 Pharmaceutical Sales Growth (2014-2019)
    • 11.3 Research Sales Growth (2014-2019)
    • 11.4 Diagnostic Sales Growth (2014-2019)

    12 Oligonucleotides Market Forecast (2019-2024)

    • 12.1 Global Oligonucleotides Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oligonucleotides Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oligonucleotides Market Forecast (2019-2024)
      • 12.2.2 Europe Oligonucleotides Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oligonucleotides Market Forecast (2019-2024)
      • 12.2.4 South America Oligonucleotides Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oligonucleotides Market Forecast (2019-2024)
    • 12.3 Oligonucleotides Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oligonucleotides Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oligonucleotides Market Share Forecast by Type (2019-2024)
    • 12.4 Oligonucleotides Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oligonucleotides Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oligonucleotides Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Oligonucleotides. Industry analysis & Market Report on Oligonucleotides is a syndicated market report, published as Global Oligonucleotides Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,735.28
      4,102.92
      5,470.56
      3,215.52
      4,823.28
      6,431.04
      544,898.40
      817,347.60
      1,089,796.80
      289,849.20
      434,773.80
      579,698.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report